Clinical Trial Update: Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase II trial evaluating concurrent docetaxel and carboplatin with radiotherapy and consolidation for locally advanced, inoperable non-small cell lung cancer. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-03-22